Q&A: HIV ART Safety Part 1
Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities

Released: January 17, 2023

Expiration: January 16, 2024

Marta Boffito
Marta Boffito, MD, PhD, FRCP, MBA
Jens D. Lundgren
Jens D. Lundgren, MD, DMSc

Activity

Progress
1
Course Completed

In this episode, Marta Boffito, MD, PhD, FRCP, and Jens D. Lundgren, MD, DMSc, address key considerations when evaluating antiretroviral therapy safety and tolerability in aging patients and those with possible cardiometabolic toxicities, including:

  • Monitoring for cardiometabolic syndromes (eg, lipid panels, coronary artery calcification scores) 
  • Approaching antiretroviral-related weight gain in clinical practice 
  • Interpreting results from RESPOND on cardiovascular risk with integrase strand transfer inhibitors
  • Collaborating with other specialties (eg, cardiologists, dietitians) to provide a multidisciplinary approach for managing comorbidities, including prevention and management